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Receptor-interacting protein 140 (RIP140), a nuclear
receptor corepressor, is important for lipid and
glucose metabolism. In adipocytes, RIP140 can be
phosphorylated by protein kinase C epsilon (PKC3),
followed by arginine methylation, and exported to
the cytoplasm. This study demonstrates for the first
time a cytoplasmic function for RIP140: to counteract
insulin-stimulated glucose transporter 4 (GLUT4)
membrane partitioning and glucose uptake in adipo-
cytes. Cytoplasmic RIP140 interacts with the Akt
substrate AS160, thereby impeding AS160 phos-
phorylation by Akt; this in turn reduces GLUT4 traf-
ficking. This signal transduction pathway can be
recapitulated in the epididymal adipocytes of diet-
induced obesemice: nuclear PKC3 is activated, cyto-
plasmic RIP140 increases, and GLUT4 trafficking
and glucose uptake are reduced. The data reveal
a new, cytoplasmic function for RIP140 as a negative
regulator of GLUT4 trafficking and glucose uptake,
and shed insight into the regulation of basal and
insulin-stimulated glucose disposal by a nuclear-
initiated counteracting mechanism.
INTRODUCTION
Insulin sensitivity is key to the maintenance of systemic energy
homeostasis, ensuring that metabolically healthy individuals
can adapt to various fuel conditions by sensing blood glucose
load and triggering its disposal (Herman and Kahn, 2006). The
inability of an individual to respond to insulin signals to remove
glucose, i.e., insulin resistance (IR), is the hallmark of type 2 dia-
betes and can be caused by a variety of factors (Doria et al.,
2008; Herman and Kahn, 2006; Schenk et al., 2008). Once IR is
detected clinically, reversing the progression of the disease is
often difficult. Early markers for IR, especially those involved in
the regulation of insulin signaling and glucose disposal, are
therefore important to further understand disease progression
and develop therapeutic agents.
The principal mechanism for glucose disposal, insulin-stimu-
lated glucose uptake, mainly involves glucose transporter 4516 Cell Metabolism 10, 516–523, December 2, 2009 ª2009 Elsevie(GLUT4) (Huang and Czech, 2007). Insulin activates a cascade
of intracellular signaling events, including the mitogen-activated
protein kinase pathway for growth and the phosphoinositide
3-kinase (PI3K)-Akt pathway for glycogen and protein synthesis
and glucose uptake via GLUT4 (Herman and Kahn, 2006; Tilg
and Moschen, 2008). IR is mainly attributed to defects in
insulin-signaling pathways (Guilherme et al., 2008; Muoio and
Newgard, 2006; Schenk et al., 2008; Tilg and Moschen, 2008;
Wellen and Hotamisligil, 2005), as well as GLUT4 synthesis,
translocation, trafficking, and downregulation (Guilherme et al.,
2008; Herman and Kahn, 2006; Huang and Czech, 2007). To
this end, insulin stimulates the translocation of GLUT4 storage
vesicles (GSVs) from intracellular compartments to the plasma
membrane (PM), a key step regulating GLUT4 traffic.
Among the thirteen GLUTs, GLUT4 is the only isoform that is
insulin responsive, and it is expressed predominantly in muscle
and adipose tissues (Huang and Czech, 2007). Insulin-stimu-
lated GLUT4 partitioning to the PM is mediated primarily by
PI3K-activated Akt, which phosphorylates AS160, a Rab-
GTPase-activating protein (Rab-GAP) (Hou and Pessin, 2007;
Sakamoto and Holman, 2008). Phosphorylated AS160 (pAS160)
is thought to become inactive, allowing more Rab-GTP to accu-
mulate, which facilitates GSV trafficking to the PM (Larance
et al., 2005; Ng et al., 2008; Sakamoto and Holman, 2008;
Sano et al., 2003).
Receptor-interacting protein 140 (RIP140), a widely known
transcription corepressor (Christian et al., 2006; Wei, 2004),
can be modified extensively by posttranslational modifications
(PTMs) (Mostaqul Huq et al., 2008). Certain PTMs augment its
nuclear activity (Gupta et al., 2005; Ho et al., 2008; Huq et al.,
2009a, 2009b, 2007), whereas a specific cascade of sequential
PTMs, initiated by nuclear PKC3 phosphorylation of RIP140s
Ser-102 and Ser-1003, triggers its export to the cytoplasm in
adipocytes (Gupta et al., 2008; Mostaqul Huq et al., 2006). This
report uncovers a new functional role for RIP140 in the adipocyte
cytoplasm—to negatively regulate insulin-stimulated GLUT4
trafficking—and determines the mechanism of this action.
RESULTS
Increased Cytoplasmic RIP140 Reduces GLUT4
Trafficking in 3T3-L1 Adipocytes
We first found cytoplasmic RIP140 readily detectable in 4 day
differentiated cells, and robustly detected in 8 day differentiatedr Inc.
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to insulin stimulation in glucose uptake than the 8 day cells (Fig-
ure 1B). Consistently, insulin dramatically stimulated GLUT4 par-
titioning into the PM of 4 day cells. The 8 day cells had higher
basal glucose uptake and PM-associated GLUT4 levels, which
could be stimulated by insulin (Figure 1C). Insulin-stimulated
glucose uptake in these 3T3-L1 adipocytes seems lower than
that of some reported studies, which might be due to difference
in experimental procedures such as the differentiation cocktail
(Romero et al., 2000).
Cytoplasmic RIP140 was evident in 4 day cells, and its levels
increased by day 8; similarly, PKC3 levels also increased during
differentiation (Figure 1C). When RIP140 and PKC3 were
knocked down individually, both basal and insulin-stimulated,
PM-associated GLUT4 levels in 8 day cells increased signifi-
cantly (Figure 1D), and basal and insulin-stimulated glucose
uptake was also enhanced significantly (Figure 1E). While
GLUT4 mRNA level was not altered by RIP140 or PKC3 silencing
(Figure 1D), total GLUT4 protein level was upregulated (2.5
folds) by RIP140 silencing (Figure S1), indicating additional func-
tions, beyond affecting GLUT4 protein level, of RIP140 to modu-
late glucose uptake.
GLUT4 trafficking was assessed using G7 adipocytes which
stably express myc-GLUT4-EGFP (Yu et al., 2007). Silencing
RIP140 or PKC3 increased, by approximately 2-fold, the number
of cells exhibiting surface-stained myc-GLUT4 (i.e., an intact
myc rim stained with anti-myc) (Figure 1F); this was confirmed
by immunoblotting (Figure S2). Myc-GLUT4 recycling was
monitored by incubating G7 adipocytes with anti-myc for 60
min in the presence or absence of insulin, followed by fixation
and permeabilization to stain internalized myc-GLUT4 with a
secondary antibody. The internalized myc-GLUT4 signal was
stronger in both RIP140- and PKC3-silenced cells (Figure 1G).
Overall, these results suggest a functional role for both
RIP140 and PKC3 in negatively regulating GLUT4 trafficking to
the PM.
We previously identified nuclear PKC3 activation as an initial
trigger to stimulate the export of nuclear RIP140. Two RIP140
mutants, CP (a phosphor-mimetic export enhancer) and CN (a
phosphor-deficient mutant with reduced export), were used to
rescue RIP140/ adipocytes (Figure 2A). Re-expressing the
wild-type, or CP, but not CN, RIP140 reduced both basal and
insulin-stimulated GLUT4 partitioning to the PM. Likewise,
glucose uptake of the RIP140 null cells was significantly reduced
by expressing WT or CP RIP140, but unaffected by the CN
mutant (Figure 2B). Taken together, these results indicate that
cytoplasmic RIP140 negatively regulates basal and insulin-stim-
ulated GLUT4 trafficking to the cell surface in these adipocytes.
Furthermore, this effect can be initiated by PKC3-mediated
phosphorylation of RIP140 in the nucleus.
Regulation of AS160 Phosphorylation by RIP140
Several regulatory points of GLUT4 trafficking where RIP140
might play a role were examined. We found that RIP140 directly
affected the phosphorylation of AS160 on Thr-642 by Akt
(Figure 2C). Neither RIP140 nor PKC3 silencing affected the
basal or insulin-activated Akt or ERK1/2 activation profiles, but
both manipulations enhanced pAS160 levels (Figure 2D).
AS160 protein, but not its mRNA, level was decreased slightlyCell Mby silencing RIP140 or PKC3. Therefore, RIP140 silencing slightly
decreases AS160 protein expression, but profoundly increases
its phosphorylation. Treatment with PKC effectors indicated
that PKC activation increased RIP140/AS160 complex formation
(Figure 2E), suggesting that such complex formation might
inhibit the phosphorylation of AS160.
RIP140 Directly Interacts with AS160 to Impede Akt
Phosphorylation of AS160
The direct interaction and in vivo complex formation of RIP140
with AS160 was confirmed using glutathione S-transferase
(GST) pull-down (Figure 3A) and coimmunoprecipitation (Fig-
ure 3B). The AS160-interaction domain of RIP140 was mapped
to its amino (peptides 1–350) and carboxyl (peptides 717–end)
termini. The interaction of RIP140 with AS160 interfered with
the ability of AS160 to interact with Akt (Figure 3C). In vitro kinase
assays confirmed that RIP140 reduced AS160 phosphorylation
by approximately 50% (Figure 3D). Thus, RIP140 interacts
directly with AS160, impeding its phosphorylation by Akt, and
presumably maintaining the GAP activity of AS160. This would
inactivate downstream targets such as Rab-GTPases, thereby
reducing GSV trafficking.
High-Fat Diet Activates Nuclear PKC3 and Promotes
Cytoplasmic RIP140 Accumulation
To determine if this signaling pathway could be recapitulated in
animals under physiological or pathophysiological conditions,
mice were fed a normal diet (ND) or a high-fat diet (HFD) for
5 weeks. Primary adipocytes from these mice were compared
with respect to RIP140 subcellular distribution, nuclear PKC3
activation and glucose uptake. Cytoplasmic RIP140 was clearly
detected in the white adipocytes from epididymides of HFD-fed
mice, but not in the ND controls (Figure 4A, top). Indeed, the
number of adipocytes expressing cytoplasmic RIP140 was
nearly 3-fold higher in HFD mice than ND mice (Figure 4A,
bottom). (The specificity of anti-RIP140 was validated by immu-
nohistochemistry and immunoblotting [Figures S3 and S4]). Like-
wise, the response of glucose uptake to insulin decreased from
a nearly 6-fold stimulation in ND mice to only about a 1.5-fold
increase in HFD adipocytes (Figure 4B), although basal glucose
uptake in primary adipocytes was comparable between HFD
and ND groups. This is different from the apparent elevation of
basal glucose uptake levels in later (day 8) in vitro differentiated
adipocytes (Figure 1), which might be due to factors varied
between in vivo and in vitro conditions. RIP140 was located
predominantly in the nuclei of ND adipocytes but appeared
abundantly in the cytoplasm of HFD adipocytes (Figure 4C).
Total RIP140 levels also increased in HFD adipocytes, which
appeared to partially result from increased mRNA levels (Fig-
ure 4C, bottom). Finally, nuclear PKC3 activity was also signifi-
cantly (4-fold) higher in HFD adipocytes (Figure 4D). Previous
studies showed that long-term (>12 weeks) exposure to a HFD
decreases insulin-stimulated signaling pathways, including
phosphorylation of Akt, by regulating insulin receptor substrate’s
modifications (Schenk et al., 2008; Wellen and Hotamisligil,
2005). In the present study, feeding an HFD for only 5 weeks
profoundly decreased insulin-stimulated AS160 phosphoryla-
tion, but not Akt activation (Figures 4E and S5).etabolism 10, 516–523, December 2, 2009 ª2009 Elsevier Inc. 517
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RIP140-knockout animals exhibit a phenotype mostly opposite
to that of metabolic syndromes (Christian et al., 2006; White
et al., 2008). At least one study has shown that silencing
RIP140 improves insulin-stimulated glucose uptake in adipo-
cytes (Powelka et al., 2006). These effects have been attributed
to the nuclear actions of RIP140, largely because of its widely
recognized function as a nuclear receptor coregulator (Christian
et al., 2006; Mostaqul Huq et al., 2008; Puri et al., 2008). Here we
report, for the first time, a new functional role for the cytoplasmic
form of RIP140 as a negative regulator of GLUT4 trafficking.
Cytoplasmic RIP140 interacts directly with AS160, preventing
its phosphorylation by Akt, and thus, its inactivation. Maintaining
AS160 in its active state preserves its ability to inactivate Rab-
GTPase, thus reducing GLUT4 trafficking. The fact that in mice
exposure to a high-fat diet for 5 weeks readily elevates the level
of RIP140 (particularly cytoplasmic RIP140) in epididymal
adipose tissues suggests a role for RIP140 in the progression
of IR in diet-induced obesity. Interestingly, the mechanism of
action appears to involve, at least in part, the activation of
nuclear PKC3, which phosphorylates nuclear RIP140 and facili-
tates its subsequent export to the cytoplasm.
Most studies of IR focus on membrane-elicited insulin signal
transduction pathways that stimulate GLUT4 trafficking. The
nuclear-initiated signaling pathway identified here negatively
regulates GLUT4 trafficking by increasing the export of
RIP140. This conclusion is supported by the apparently effective
rescue of RIP140 null cells by the CP, but not the CN, RIP140
mutant (Figures 2A and 2B). However, we have not completely
ruled out contributions from the nuclear-localized RIP140.
Rescuing RIP140 null adipocytes with RIP140 wild-type or its
cytoplasm-localized form (CP) slightly decreases GLUT4 protein
level (Figure 2A), indicating certain unknown activity of cyto-
plasmic RIP140 that could modulate total GLUT4 protein level.
Since manipulating the RIP140 level (or altering its PTMs) in
3T3-L1 adipocytes did not change GLUT4 mRNA levels
(Figure 1D), the negative regulatory effect of RIP140 on GLUT4
trafficking does not involve its traditional function as a transcrip-
tional corepressor. A recent study has reported that RIP140 is
a key regulator in muscle metabolism (Seth et al., 2007). It would
be interesting to determine if the mechanism described here
for RIP140 function in adipocytes functions similarly in muscle
cells.Cell MInflammation and ER stress in adipose tissue are critical
events in diet-induced IR and subsequent diabetes (Guilherme
et al., 2008; Schenk et al., 2008; Wellen and Hotamisligil,
2005). However, whether inflammation and ER stress represent
early contributing events to IR has been debated (Schenk
et al., 2008; Wellen and Hotamisligil, 2005). In fact, several
studies showed that diet-induced inflammation and ER stress
in adipose tissues are relatively late events (Duffaut et al.,
2009; Ozcan et al., 2006). In this study, feeding mice a HFD for
5 weeks readily stimulated cytoplasmic RIP140 levels and
reduced insulin stimulation of glucose uptake, without impairing
Akt activation. This suggests that HFD-induced accumulation of
cytoplasmic RIP140 could be an early event that dampens
insulin sensitivity in adipocytes. Whether and how cytoplasmic
RIP140 is related to inflammation or ER stress under prolonged
feeding with a HFD needs to be evaluated.
PKC3 activation in liver and muscle is an important factor for
impaired insulin-stimulated glucose disposal (Laybutt et al.,
1999; Samuel et al., 2007). Targeting PKC3 in b cells elevates
insulin secretion, whereas PKC3 deletion augments whole-body
glucose disposal (Schmitz-Peiffer and Biden, 2008; Schmitz-
Peiffer et al., 2007). This study shows that nuclear PKC3 activity
could also indicate a pathophysiological condition, at least with
respect to the control of GLUT4 trafficking in adipocytes.
AS160 is a newly identified GAP that functions as a negative
regulator of several Rab-GTPases involved in vesicular trans-
port, docking, and fusion (Hou and Pessin, 2007; Sakamoto
and Holman, 2008; Sano et al., 2003). Our results show that
RIP140 markedly downregulates AS160 phosphorylation, with
only a slight effect on AS160 protein expression and no effect
on its mRNA levels. Thus, cytoplasmic RIP140 could also regu-
late AS160 protein levels via other, as-yet-unknown, posttran-
scriptional mechanisms. Whether RIP140 regulates trafficking
of other vesicles remains to be determined.
EXPERIMENTAL PROCEDURES
Cell Culture
COS-1 cells, 3T3-L1 fibroblasts, and RIP140/mouse embryonic fibroblasts
(MEF) were maintained and differentiated as described (Ho et al., 2008). G7
fibroblasts were maintained and differentiated as described (Yu et al., 2007).
Transfection was conducted with Lipofectamine 2000 (Invitrogen) as
described (Gupta et al., 2008) or Lipofectamine LTX according to themanufac-
turer’s instructions. siRNA (QIAGEN) was introduced using a DeliverX Plus
siRNA transfection kit (Panomics).Figure 1. Increase of Basal and Insulin-Stimulated GLUT4 Trafficking and Glucose Uptake in Adipocytes by Knockdown of RIP140 or PKC3
(A) Cytoplasmic RIP140 in 3T3-L1 adipocytes (on day 4 and day 8 of differentiation). Scale bar = 40 mM. (B) Glucose uptake in 3T3-L1 adipocytes that were serum
starved (3 hr) and stimulated with or without insulin (100 nM) for 20 min.
(C) Membrane partitioning of GLUT4; distribution and expression of RIP140 in differentiated 3T3-L1 adipocytes in the absence or presence of 170 nM insulin for
20 min. Levels of PKC3 and other marker proteins were also monitored. PM: plasma membrane; LDM: low-density membrane; Nu: nuclear fraction; Cyto: cyto-
plasmic fraction.
(D) Basal and insulin-stimulatedGLUT4 partitioning in 3T3-L1 adipocytes. Knockdownswere conducted on day 5 of differentiation; insulin (170 nM) stimulation for
20minwas performed on day 8. Left: Distributions of GLUT4, RIP140, andmarker proteins. GLUT4mRNA levels weremonitored by RT-PCR. TM: total membrane
fraction; W.C.L.: whole-cell lysate. Right: Relative GLUT4 levels in PM, normalized to the non-insulin-treated control. *: p < 0.05 versus control; **: p < 0.05 versus
insulin treatment (n = 3).
(E) Glucose uptake in differentiated 3T3-L1 adipocytes (day 8).
(F) Myc-GLUT4-GFP labeling in G7 adipocytes. Top:Membrane-localizedGLUT4was detectedwith anti-myc. Bar = 30 mM.Bottom:Quantification by scoring the
percentage of cells with an intact myc rim on the surface. *: p < 0.05 versus control; **: p < 0.05 versus insulin treatment (n = 3).
(G) Immunohistochemical staining of recycled myc-GLUT4 in G7 adipocytes. Bar = 40 mM. Data are presented as means ± SD.etabolism 10, 516–523, December 2, 2009 ª2009 Elsevier Inc. 519
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(A) GLUT4 trafficking. RIP140 null adipocytes were differentiated and transfected with wild-type (WT) RIP140, a PKC3 phosphormimetic mutant (CP), or a consti-
tutive negative mutant (CN) on day 5. Cells were starved for 3 hr and then treated with or without insulin for 20 min and lysates were prepared on day 8.
(B) Glucose uptake in RIP140 null and rescued adipocytes. Data are presented as means ± SD *: p < 0.05 versus control treatment; **: p < 0.05 versus insulin
treatment in control vector-transfected cells (n = 3).
(C) Summary of GLUT4 trafficking regulated by AS160, with the potential point of RIP140 intervention indicated.
(D) Top: Phosphorylation of AS160 and related kinases in G7 adipocytes, with and without insulin (170 nM) stimulation for 20 min. Lower: mRNA levels monitored
by RT-PCR.520 Cell Metabolism 10, 516–523, December 2, 2009 ª2009 Elsevier Inc.
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G7 adipocytes were starved (3 hr) in serum-free medium and treated with
100 nM insulin (20 min); cells were fixed and incubated with anti-myc (2 hr,
4C). After washing, cells were stained with Cy3-conjugated secondary anti-
body. Images were acquired on an Olympus FluoView1000 IX2 inverted
confocal microscope. GLUT4 recycling was performed as described (Larance
et al., 2005).
In Vitro Competition Assays for Protein Interaction
In vitro protein interaction assay was performed as described (Ho et al., 2008)
to examine competition between RIP140 and AS160. Flag-RIP140 was
(E) RIP140/AS160 complex formation in 3T3-L1 adipocytes. Day-8 differentiated cells were treated with control vehicle (Ctrl), 4 mM of phorbol 12-myristate
13-acetate (PKC activator) or 50 mM of calphastin (PKC inhibitor) for 3 hr. Left: Nuclear and cytoplasmic fractions were subjected to reciprocal immunoprecip-
itation (IP) and immunoblotting (IB) as indicated. Right: Total protein levels.
Figure 3. Direct Interaction of AS160 with
RIP140 Maintains AS160 Activity by
Impeding Akt-Mediated Phosphorylation
(A) GST pull-down assay. Top: Map of RIP140
constructs. Lower left: Interaction of isotope-
labeled full-length RIP140 with full-length GST-
AS160. Lower right: Interaction of AS160 with
various RIP140 segments.
(B) In vivo complex formation of RIP140 with
AS160 in COS-1 cells: immunoprecipitation with
anti-Flag (for Flag-RIP140) antibodies and immu-
noblotting with anti-HA (for HA-AS160). Specific
Flag-RIP140 fragments are indicated (*).
(C) Competition between RIP140 and Akt to form
complexes with AS160. GST-AS160 (5 mg) was
incubated overnight with 0.25 mg active Akt2 and
increasing amounts of Flag-RIP140 in a 0.5ml
coIP buffer. Pull-down complexes and superna-
tants were immunoblotted as indicated.
(D) Akt-mediated AS160 phosphorylation in vitro.
GST or GST-AS160 (5 mg) were incubated over-
night with or without in vitro-synthesized Flag-
RIP140 (i.e., the highest amount used in panel
C). After washing, 0.5 mg active Akt was added
to the pull-down complexes in Akt kinase buffer
for kinase reaction. pAS160 (pT642-AS160), total
AS160, and Akt were determined by immunoblot-
ting. Right: quantitative result of kinase assay for
AS160 from two independent experiments. Data
are presented as means ± SD. *: p < 0.05 versus
control.
synthesized in a transcription-translation system
(Promega) and incubated with GST-AS160 and
an equal amount of Akt2 (Upstate) in coimmuno-
precipitation buffer overnight at 4C. Details are
described in the Supplemental Data. After wash-
ing, immunocomplexes and supernatants were
analyzed with indicated antibodies on blots.
PKC3 Kinase Activity Assay
Nuclear PKC3 activity was assayed using 200 mg
of immunoprecipitated nuclear extract with
a radiometric kit (Upstate) according to the manu-
facturer’s instructions.
Statistical Analysis
Experiments were performed at least twice and
the results were the same. Results are presented
as means ± SD. Comparisons between groups were made by unpaired two-
tailed Student’s t tests. P values < 0.05 were considered to be statistically
significant.
SUPPLEMENTAL DATA
The Supplemental Data include 20 figures, Supplemental Experimental
Procedures, and Supplemental References and can be found with this article
online at http://www.cell.com/cellmetabolism/supplemental/S1550-4131(09)
00308-8.Cell Metabolism 10, 516–523, December 2, 2009 ª2009 Elsevier Inc. 521
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Figure 4. Increases in Cytoplasmic RIP140 and Nuclear PKC3 Activity in Epididymal White Adipose Tissues from Obese Mice
(A) Endogenous RIP140 in epididymal adipose tissues frommice fed ND or HFD for 5 weeks. Arrows in enlarged images (lower) point to the cytoplasmic signals of
RIP140. Scale bar = 25 mM. Right: Effect of HFD on the percentage of cytoplasmic RIP140-positive cells.
(B) Glucose uptake in epididymal adipocytes (ND: 24 mice; HFD: 16 mice).
(C) Upper left: Immunoblots of nuclear, cytoplasmic, and whole-cell RIP140 in epididymal adipocytes; each lane shows samples pooled from five mice. Relevant
protein markers were monitored. Upper right: Quantification of cytoplasmic RIP140, normalized against that in ND-fed mice. Lower left: The mRNA levels deter-
mined by RT-PCR. Lower right: Quantification of RIP140 mRNA, normalized against actin.522 Cell Metabolism 10, 516–523, December 2, 2009 ª2009 Elsevier Inc.
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